BioNexus Gene Lab Corp (BGLC) SEC Filings & Financial Intelligence
BioNexus Gene Lab Corp (BGLC) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BGLC
CIK: 1737523
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: WY
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
JP CENTURION & PARTNERS PLT
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerChuin Harn Goh
Audit LocationKuala Lumpur, Malaysia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-07 | 2026-10-05 | FORM 8-K | 0001477932-26-006075 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-14 | — | SCHEDULE 13D Filing | 0001520138-26-000354 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 Filing | 0001520138-26-000349 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 Filing | 0001520138-26-000348 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 Filing | 0001520138-26-000347 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 Filing | 0001520138-26-000346 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | 4 Filing | 0001520138-26-000345 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001477932-26-005093 | View SEC Doc Filr Page |
| 3 | 2026-08-07 | 2025-11-28 | 3 Filing | 0001520138-26-000322 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2023-08-15 | 3 Filing | 0001520138-26-000301 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2023-12-11 | 3 Filing | 0001520138-26-000300 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2022-03-07 | 3 Filing | 0001520138-26-000295 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2025-06-17 | 3 Filing | 0001520138-26-000294 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2025-06-17 | 3 Filing | 0001520138-26-000293 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | FORM 8-K | 0001477932-26-004556 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-05-29 | FORM 8-K | 0001477932-26-003658 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001477932-26-003242 | View SEC Doc Filr Page |
| 10-K | 2026-04-14 | 2025-12-31 | FORM 10-K | 0001477932-26-002218 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001477932-26-001877 | View SEC Doc Filr Page |
| 8-K | 2026-03-17 | 2026-03-11 | FORM 8-K | 0001477932-26-001379 | View SEC Doc Filr Page |
| 8-K | 2026-02-23 | 2026-02-23 | FORM 8-K | 0001477932-26-000964 | View SEC Doc Filr Page |
| 8-K | 2026-02-03 | 2026-01-28 | FORM 8-K | 0001477932-26-000610 | View SEC Doc Filr Page |
| 8-K | 2025-12-30 | 2025-12-24 | FORM 8-K | 0001477932-25-009240 | View SEC Doc Filr Page |
| 8-K | 2025-12-23 | 2025-12-19 | FORM 8-K | 0001477932-25-009186 | View SEC Doc Filr Page |
| DEF 14A | 2025-12-03 | 2025-12-24 | DEF 14A | 0001477932-25-008757 | View SEC Doc Filr Page |